By summy 0 Comment

Healthcare Knuggets

Healthcare Knuggets

Mar 14, 2026

Subject: 🏥 Iron Sharpens Irons: Sword Health’s AI Care Takeover

Sender: hospitalogy@workweek.comD

Chatlink: https://summymonkey.me/wp-json/chatlink/v1/sm-chat?chat=MjAyNjAzMTIxODU0MDYuNDQ2NDI0ODYuODQxN0BzYWlsdGhydS5jb218fGNrc20raGVhbHRoY2FyZUBzdW1teW1vbmtleS5tZQ==c697543dd4b1678072ed4ba61c3a8480c

Summary:

Sword Health recently launched Pulse, an AI-enabled cardiometabolic care product focused on gradual behavioral change over 4-12 months rather than aggressive interventions. Co-led by Kevin Wang, who brings personal experience with cardiometabolic conditions, the platform integrates AI (Phoenix) alongside human clinicians to engage patients continuously, including shift workers and contextual meal logging. Sword’s approach is part of a larger expansion into multiple verticals—MSK, women’s health, mental health, and now cardiometabolic—under one comprehensive AI Care platform with outcomes-based pricing.

Key points:

– Pulse is built around sustainable lifestyle habit change, not strict diets or overwhelming protocols.

– Sword expanded rapidly since 2020, acquiring Kaia Health, launching mental and women’s health programs, now cardiometabolic care.

– Cardiometabolic disease burden is vast and costly, with 185 million US Americans affected and high employer spend.

– AI Phoenix works proactively in patient care as a behavioral coach and clinical aide in a three-way chat with patients and human clinicians.

– Outcome-based pricing ties half payment to patient improvement measured by validated scales, guaranteeing ROI.

– Platform consolidation offers employers a simplified single contract across multiple health domains, leveraging economies of scale and shared AI infrastructure across 800K patients treated and 10M AI care sessions.

– Open-sourcing AI safety frameworks like Arbor and MindGuard signal Sword’s commitment to safety and transparency.

– Challenges remain about healthcare employment shifts as AI scales access.

Bonus: A macro question about AI-driven care’s impact on healthcare employment and administrative jobs, with optimism but caution about workforce transitions.

Sponsored segment: Lumeris highlights primary care access challenges and advocates for scalable AI-enabled solutions to overcome provider shortages.

Ending: Personal anecdote on mismatched bloodwork height measurement humorously rounds out the newsletter.

Subject: What AI cannot replace in medicine

Sender: newsletter@kevinmd.comD

Chatlink: https://summymonkey.me/wp-json/chatlink/v1/sm-chat?chat=YjZhODc4NWMxZTY4MTFmMTlhMDAxNmZmZTIxODEzYWZAc210cC1zb2ktZzA4LTEyMi5hd2ViZXIuY29tfHxja3NtK2hlYWx0aGNhcmVAc3VtbXltb25rZXkubWU=431216d89be41aecade8cc69fb143c35c

Summary:

Highlights from recent medical insights shared on KevinMD, focusing on AI’s role limitations in medicine, racial disparities, burnout, and emerging controversies:

  • Physicians urged to embrace AI as a complementary tool that supports but does not replace clinical judgment or the patient-physician relationship.

  • Pancreatic cancer disproportionately affects Black Americans, prompting calls for race-conscious early screening protocols.

  • The importance of cultivating practical wisdom and strong clinical judgment is underscored beyond raw medical knowledge.

  • Comparative health equity strategies among diverse nations and the barriers faced by Black students due to internship shortages and systemic biases in psychology education.

  • Reconsideration of the lipid hypothesis and statins with evidence suggesting minimal mortality benefit from LDL lowering.

  • Reflections on the safety of SGLT2 inhibitors in type 1 diabetes amid benefits and serious risks.

  • Leadership is critical in preventing burnout, with calls for systemic change.

  • Critique of the “Make America Healthy Again” plan as anti-science compared to effective primary care and public health measures.

  • Integrating faith with academia is posited as essential for holistic impact in health.

Additionally, podcasts and subscriptions to the daily KevinMD podcast and newsletter are promoted.

Subject: Can the White House steer MAHA away from vaccine skepticism?

Sender: newsletter@statnews.comD

Chatlink: https://summymonkey.me/wp-json/chatlink/v1/sm-chat?chat=MTc3MzM5NjUwMzA0Ny4zZWNjOGMxMS1hMmNkLTQ2YWQtODc2Ni1mZDZhNDMzYTNhNDdAYmY1MnguaHVic3BvdGVtYWlsLm5ldHx8Y2tzbStoZWFsdGhjYXJlQHN1bW15bW9ua2V5Lm1lc4af4d8d5922475869cb2ef4a240e8b2c

Summary:

An in-depth analysis of current political and public health tensions:

  • Health Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” (MAHA) campaign, associated with vaccine skepticism, faces pushback from the Biden White House and some in the Trump administration who want to distance themselves from controversial anti-vaccine sentiments ahead of elections.

  • FDA draft guidance hints at potential authorization of new vape flavors (coffee, mint, cinnamon), raising concerns among public health advocates about youth vaping, balanced against adult harm reduction arguments.

  • Recent scientific discovery identifying Src protein on cancer cell surfaces offers promising immunotherapy targets for solid tumors.

  • FDA advisory committee recommends using WHO-recommended flu vaccine strains next season, while flu shot supply is shrinking.

  • Polls show Americans credit Trump more than Biden for efforts to lower drug prices, despite both administrations’ initiatives.

  • Features include how surrealism relates to dementia care, and other health and policy stories.

Subject: 🥼 AI for doctors

Sender: caitlin@axios.comD

Chatlink: https://summymonkey.me/wp-json/chatlink/v1/sm-chat?chat=MjAyNjAzMTMwNjMxMTguNDQ2ODAyMjUuNjA3NjlAc2FpbHRocnUuY29tfHxja3NtK2hlYWx0aGNhcmVAc3VtbXltb25rZXkubWU=e465dcce5e38f1b8b6327636c9825c1ec

Summary:

Exploring how AI is increasingly integrated into physicians’ workflows with cautious optimism:

  • Survey shows 81% of doctors use or plan to use AI for tasks like summarizing research, creating discharge instructions, chart summaries, billing coding, and documentation.

  • AI helps with workload reduction amid burnout and workforce shortages but is not yet ready to replace clinical diagnosis or treatment planning due to reliability concerns.

  • Accreditation organizations are working to identify trustworthy AI vendors amidst varied quality in AI health tools.

  • The patient safety community flags diagnostic AI as a top concern for 2026 due to risk of errors.

  • Experts believe that widespread adoption for administrative assistance will pave the way for riskier clinical AI applications with increasing trust.

  • A personal story of delayed diagnosis in a rare disease (AL amyloidosis) illustrates AI’s promise to assist non-specialist physicians and bridge gaps between generalists and specialists.

  • Challenges remain in using AI to narrow complex symptom profiles, emphasizing that AI is a tool to augment, not replace, clinical judgment.

Sponsored section: Claritev offers AI-powered healthcare claims repricing to boost affordability and price transparency.

Subject: What to expect at next week’s Breakthrough East + last call for NYC seats

Sender: marketing@statnews.comD

Chatlink: https://summymonkey.me/wp-json/chatlink/v1/sm-chat?chat=MTc3MzQxNTI1ODEyNy4wMzE4YjdkNC1mNjg0LTQ2ZWQtODMwYS04NGUyNTEyZWI2YmVAYmY1MnguaHVic3BvdGVtYWlsLm5ldHx8Y2tzbStoZWFsdGhjYXJlQHN1bW15bW9ua2V5Lm1l3756a2123437fe310d05cf3498717b61c

Summary:

Preview of the STAT Breakthrough Summit East event, spotlighting health and pharmaceutical industry leaders, including:

  • Sessions with former FDA commissioner Robert Califf, drug pricing negotiators from Trump and Biden’s administrations, and biotech veterans including Stelios Papadopoulos.

  • Panel discussions featuring R&D heads from Bristol Myers Squibb, Alnylam, and Biogen.

  • Virtual and in-person attendance options, with NYC general admission nearly sold out.

  • Registration links and listings of featured speakers provided.

  • Reminder about upcoming Breakthrough Summit West scheduled for May 2026.

Subject: No such thing as a shark? Genomes shake up shark family trees

Sender: briefing@nature.comD

Chatlink: https://summymonkey.me/wp-json/chatlink/v1/sm-chat?chat=MmM2MDU3YzUyOGZkYzZmNzNmYTE5NmQ5ZC5hYjk3NmZkMmZiLjIwMjYwMzEzMTgxNzM4LjNiMmU1M2Y0OWIuZmUxZmZjZGZAbWFpbDQ4LnN1dzkxLm1jZGx2Lm5ldHx8Y2tzbStoZWFsdGhjYXJlQHN1bW15bW9ua2V5Lm1l21e5857414a3db20d9f1fbd34036f29cc

Summary:

A science newsletter focusing on new findings and features:

  • Doom videogame inspires creative scientific projects, including neurons on silicon chips trained to play Doom, highlighting crossover between tech and science.

  • Genomic research challenges traditional shark taxonomy: unusual shark family Hexanchiformes may form a lineage distinct from other sharks, skates, and rays, affecting evolutionary trait studies.

  • Political and scientific developments around the breakup of the US National Center for Atmospheric Research amid governmental restructuring.

  • Cultural impacts of glacier loss on indigenous spiritual practices, with adaptations to the environmental changes.

  • Short story “First bot, singular” featured in Nature’s Futures series.

  • Podcast highlights the Amazon molly fish’s gene conversion mechanism as a rare asexual reproduction success.

  • Quote and satellite imagery work showing mining’s encroachment into pristine forests.

  • The newsletter encourages sharing and offers signup options for a range of Nature Briefing newsletters covering various science topics.

Stay Well!

summy
summy